COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > WHY NO INSIDER BUYER

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Aug 23, 2024 5:58pm

42 Views

Post# 36194143

RE:RE:RE:RE:RE:RE:RE:RE:RE:WHY NO INSIDER BUYER

Hopeforthebest, "The only thing that a COMPETENT BUSINESS PERSON wanys to hear is ON TIME and ON BUDGET..."

Thomas Edison went overtime and overbudget to invent a practical lightbulb. You would have cut him off and left humanity in the dark.

Gilles is not making a PopTart which anyone can do on time and on budget.
Gilles is on target to save and improve lives.

"I look forward to completing the development of technologies such as PGX, that continue to demonstrate its ability to successfully generate novel bioactive delivery systems at a quality that no other known technologies have been able to generate." Michel (Mitch) Regnier as Senior Vice President, Technical Operations

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario